Moa Life Plus Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 42

Employees

  • Stock Symbol
  • 142760

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.09
  • (As of Thursday Closing)

Moa Life Plus General Information

Description

MOA Life Plus Co Ltd engages in the research and development of healthcare products.

Contact Information

Formerly Known As
Bioleaders, BL
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • A-7, 767, Sinsu-ro
  • Suji-gu
  • Yongin, Gyeonggi 16827
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • A-7, 767, Sinsu-ro
  • Suji-gu
  • Yongin, Gyeonggi 16827
  • South Korea
+82

Moa Life Plus Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Moa Life Plus Stock Performance

As of 12-Nov-2026, Moa Life Plus’s stock price is $0.09. Its current market cap is $1.85M with 21.1M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.09 $0.07 $0.06 - $2.57 $1.85M 21.1M 1.64M -$0.46

Moa Life Plus Financials Summary

As of 30-Jun-2026, Moa Life Plus has a trailing 12-month revenue of $7.21M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 14,750 47,892 12,471 108,012
Revenue 7,208 7,881 11,455 13,955
EBITDA (8,234) (7,542) (3,274) 641
Net Income (9,421) (9,171) (5,126) 6,126
Total Assets 21,044 29,588 42,261 38,080
Total Debt 3,799 4,643 10,415 5,216
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Moa Life Plus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Moa Life Plus‘s full profile, request access.

Request a free trial

Moa Life Plus Patents

Moa Life Plus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250312395-A1 Pharmaceutical composition for alleviationn, treatment, and prevention of sarcopenia containing microorganism transformed with cell surface display vector operably linked with gene encoding myostatin and activin a proteins as active ingredient Pending 05-Apr-2024
WO-2022102894-A1 Coronavirus vaccine using replication-deficient adenovirus that simultaneously expresses coronavirus spike protein and nucleocapsid protein Inactive 10-Nov-2020
WO-2022103126-A1 Coronavirus vaccine using replication-incompetent adenovirus that simultaneously expresses coronavirus spike protein and nucleocapsid protein Inactive 10-Nov-2020
EP-3865578-A1 Surface expression vector for constitutive high-expression using promoter of galactose mutarotase gene derived from lactobacillus casei, and use thereof Pending 10-Oct-2018
EP-3865578-A4 Surface expression vector for constitutive high-expression using promoter of galactose mutarotase gene derived from lactobacillus casei, and use thereof Pending 10-Oct-2018 C12N15/67
To view Moa Life Plus’s complete patent history, request access »

Moa Life Plus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Moa Life Plus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Moa Life Plus‘s full profile, request access.

Request a free trial

Moa Life Plus Investments (1)

Moa Life Plus’s most recent deal was a Joint Venture with Quintrigen. The deal was made on 28-May-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Quintrigen 28-May-2019 Joint Venture Drug Discovery
To view Moa Life Plus’s complete investments history, request access »

Moa Life Plus ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Moa Life Plus’s complete esg history, request access »

Moa Life Plus FAQs

  • When was Moa Life Plus founded?

    Moa Life Plus was founded in 1999.

  • Where is Moa Life Plus headquartered?

    Moa Life Plus is headquartered in Yongin, South Korea.

  • What is the size of Moa Life Plus?

    Moa Life Plus has 42 total employees.

  • What industry is Moa Life Plus in?

    Moa Life Plus’s primary industry is Pharmaceuticals.

  • Is Moa Life Plus a private or public company?

    Moa Life Plus is a Public company.

  • What is Moa Life Plus’s stock symbol?

    The ticker symbol for Moa Life Plus is 142760.

  • What is the current stock price of Moa Life Plus?

    As of 12-Nov-2026 the stock price of Moa Life Plus is $0.09.

  • What is the current market cap of Moa Life Plus?

    The current market capitalization of Moa Life Plus is $1.85M.

  • What is Moa Life Plus’s current revenue?

    The trailing twelve month revenue for Moa Life Plus is $7.21M.

  • What is Moa Life Plus’s annual earnings per share (EPS)?

    Moa Life Plus’s EPS for 12 months was -$0.46.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process